Status:
COMPLETED
CSF Free Kappa Light Chain for The Diagnosis of Demyelinating Disorders
Lead Sponsor:
Aga Khan University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Brief Summary
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) which commonly leads to disability. The current preferred clinical laboratory test for the diagnosis is the detec...
Detailed Description
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) which commonly leads to disability. It is the most common disabling neurological disease found in young adults, m...
Eligibility Criteria
Inclusion
- Saved residual CSF samples positive for OCBs Saved residual CSF samples negative for OCBs
Exclusion
- None
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05347277
Start Date
June 1 2021
End Date
August 31 2021
Last Update
April 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Chemistry, Sopari wala building
Karachi, Sindh, Pakistan, 74800